REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,148,458 | +33.3% | 361,679 | +194.0% | 0.45% | +36.3% |
| Q2 2023 | $3,113,130 | -56.5% | 123,000 | -46.5% | 0.33% | -58.3% |
| Q1 2023 | $7,159,900 | -11.4% | 230,000 | -47.5% | 0.79% | -6.9% |
| Q4 2022 | $8,085,480 | -6.6% | 438,000 | +12.9% | 0.84% | -6.8% |
| Q3 2022 | $8,656,000 | +39.2% | 388,000 | -13.8% | 0.91% | +28.1% |
| Q2 2022 | $6,219,000 | +60.8% | 450,000 | +126.9% | 0.71% | +85.1% |
| Q1 2022 | $3,868,000 | -56.6% | 198,358 | -38.0% | 0.38% | -39.0% |
| Q3 2021 | $8,915,000 | +11.4% | 320,000 | +18.5% | 0.63% | +15.3% |
| Q2 2021 | $8,003,000 | +30.2% | 270,000 | +22.7% | 0.54% | +26.6% |
| Q1 2021 | $6,149,000 | -1.4% | 220,000 | 0.0% | 0.43% | -15.7% |
| Q4 2020 | $6,235,000 | +12.7% | 220,000 | 0.0% | 0.51% | +3.5% |
| Q3 2020 | $5,531,000 | +3.0% | 220,000 | 0.0% | 0.49% | -15.2% |
| Q2 2020 | $5,372,000 | +65.0% | 220,000 | 0.0% | 0.58% | +27.2% |
| Q1 2020 | $3,256,000 | -19.8% | 220,000 | -12.0% | 0.46% | +2.5% |
| Q4 2019 | $4,058,000 | +79.5% | 250,000 | +43.7% | 0.44% | +57.2% |
| Q3 2019 | $2,261,000 | -9.8% | 173,917 | -10.0% | 0.28% | +2.5% |
| Q2 2019 | $2,506,000 | -17.7% | 193,181 | 0.0% | 0.28% | -22.5% |
| Q1 2019 | $3,045,000 | -21.7% | 193,181 | 0.0% | 0.36% | -20.0% |
| Q4 2018 | $3,889,000 | -23.0% | 193,181 | -4.9% | 0.44% | -12.1% |
| Q3 2018 | $5,049,000 | -9.5% | 203,181 | 0.0% | 0.51% | -11.4% |
| Q2 2018 | $5,577,000 | -10.9% | 203,181 | 0.0% | 0.57% | -25.9% |
| Q1 2018 | $6,258,000 | -4.1% | 203,181 | +11.3% | 0.77% | -12.6% |
| Q4 2017 | $6,527,000 | -3.8% | 182,580 | -25.9% | 0.88% | +1.7% |
| Q3 2017 | $6,788,000 | +16.9% | 246,400 | +12.0% | 0.87% | +4.0% |
| Q2 2017 | $5,808,000 | +33.0% | 220,000 | +4.8% | 0.83% | +20.5% |
| Q1 2017 | $4,368,000 | +0.5% | 210,000 | 0.0% | 0.69% | -16.9% |
| Q4 2016 | $4,347,000 | -99.9% | 210,000 | 0.0% | 0.83% | +54.0% |
| Q3 2016 | $3,404,100,000 | +113673.4% | 210,000 | -4.5% | 0.54% | +1.9% |
| Q2 2016 | $2,992,000 | +0.8% | 220,000 | +29.4% | 0.53% | -9.8% |
| Q1 2016 | $2,968,000 | -49.8% | 170,000 | -1.7% | 0.59% | -34.1% |
| Q4 2015 | $5,910,000 | +34.2% | 173,000 | +16.9% | 0.89% | +27.4% |
| Q3 2015 | $4,404,000 | -19.9% | 148,000 | -14.0% | 0.70% | +6.2% |
| Q2 2015 | $5,501,000 | +12.4% | 172,000 | -27.1% | 0.66% | -19.9% |
| Q1 2015 | $4,892,000 | +128.2% | 236,000 | +86.5% | 0.82% | +32.9% |
| Q4 2014 | $2,144,000 | +5.4% | 126,574 | +20.3% | 0.62% | +4.2% |
| Q3 2014 | $2,035,000 | -27.0% | 105,255 | +28.4% | 0.60% | -27.9% |
| Q2 2014 | $2,788,000 | +80.1% | 82,000 | +66.9% | 0.83% | +77.8% |
| Q1 2014 | $1,548,000 | – | 49,135 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |